The clinical significance of interferon inducible protein-10 in chronic hepatitis C patients with genotype I undergoing pegylated interferon and ribavirin therapy

被引：0
|
作者：
Kim, Chung Ho
Kim, Ji Hoon
Jong, Young Kul
Kim, Jeong Han
Choi, Jong Hwan
Hong, Seong Kweon
Ju, Moon Kyung
Lee, Beom Jae
Yim, Hyung Joon
Yeon, Jong Eun
Park, Jong-Jae
Kim, Jae Seon
Bak, Young Tae
Byun, Kwan Soo
机构：
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2008年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A42 / A42
页数：1
相关论文
共 50 条
  • [1] Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin Nonresponders
    Rustgi, Vinod K.
    Lee, William M.
    Lawitz, Eric
    Gordon, Stuart C.
    Afdhal, Nezam
    Poordad, Fred
    Bonkovsky, Herbert L.
    Bengtsson, Leif
    Chandorkar, Gurudatt
    Harding, Matthew
    McNair, Lindsay
    Aalyson, Molly
    Alam, John
    Kauffman, Robert
    Gharakhanian, Shahin
    McHutchison, John G.
    HEPATOLOGY, 2009, 50 (06) : 1719 - 1726
  • [2] THE IMPACT OF AGE DEPENDENT UTILITY ON THE COST EFFECTIVENESS OF PEGYLATED INTERFERON AND RIBAVIRIN VERSUS INTERFERON AND RIBAVIRIN AS THERAPY FOR GENOTYPE I PATIENTS WITH CHRONIC HEPATITIS C
    McEwan, P.
    Yuan, Y.
    Townsend, R.
    Kim, R. W.
    VALUE IN HEALTH, 2010, 13 (03) : A193 - A193
  • [3] Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C
    Matsuura, Kentaro
    Watanabe, Tsunamasa
    Iijima, Sayuki
    Murakami, Shuko
    Fujiwara, Kei
    Orito, Etsuro
    Iio, Etsuko
    Endo, Mio
    Kusakabe, Atsunori
    Shinkai, Noboru
    Miyaki, Tomokatsu
    Nojiri, Shunsuke
    Joh, Takashi
    Tanaka, Yasuhito
    HEPATOLOGY RESEARCH, 2014, 44 (12) : 1208 - 1216
  • [4] Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
    Legrand-Abravanel, F
    Nicot, F
    Boulestin, A
    Sandres-Sauné, K
    Vinel, JP
    Alric, L
    Izopet, J
    JOURNAL OF MEDICAL VIROLOGY, 2005, 77 (01) : 66 - 69
  • [5] Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients
    Oton, E
    Barcena, R
    Garcia-Garzon, S
    Moreno-Zamora, A
    Moreno, A
    Garcia-Gonzalez, M
    Blesa, C
    Foruny, JR
    Ruiz, P
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3963 - 3964
  • [6] Comparison of combination therapy of pegylated interferon and ribavirin with conventional interferon and ribavirin in chronic hepatitis C in Korea
    Kang, Myoung Joo
    Jung, Eun Uk
    Park, Sang Won
    Choi, Paul
    Kim, Ji Hyun
    Park, Sung Jae
    Park, Eun Taek
    Lee, Youn Jae
    Lee, Sang Hyuk
    Seol, Sang Yong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A217 - A217
  • [7] Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan
    Kogure, Takayuki
    Ueno, Yoshiyuki
    Fukushima, Koji
    Nagasaki, Futoshi
    Kondo, Yasuteru
    Inoue, Jun
    Matsuda, Yasunori
    Kakazu, Eiji
    Yamamoto, Takeshi
    Onodera, Hiroyoshi
    Miyazaki, Yutaka
    Okamoto, Hiromasa
    Akahane, Takehiro
    Kobayashi, Tomoo
    Mano, Yutaka
    Iwasaki, Takao
    Ishii, Motoyasu
    Shimosegawa, Tooru
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (47) : 7225 - 7230
  • [8] Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan
    Takayuki Kogure
    Yoshiyuki Ueno
    Koji Fukushima
    Futoshi Nagasaki
    Yasuteru Kondo
    Jun Inoue
    Yasunori Matsuda
    Eiji Kakazu
    Takeshi Yamamoto
    Hiroyoshi Onodera
    Yutaka Miyazaki
    Hiromasa Okamoto
    Takehiro Akahane
    Tomoo Kobayashi
    Yutaka Mano
    Takao Iwasaki
    Motoyasu Ishii
    Tooru Shimosegawa
    World Journal of Gastroenterology, 2008, 14 (47) : 7225 - 7230
  • [9] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Aizawa, Nobuhiro
    Enomoto, Hirayuki
    Takashima, Tomoyuki
    Sakai, Yoshiyuki
    Iwata, Kazunari
    Ikeda, Naoto
    Tanaka, Hironori
    Iwata, Yoshinori
    Saito, Masaki
    Imanishi, Hiroyasu
    Iijima, Hiroko
    Nishiguchi, Shuhei
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 1253 - 1263
  • [10] Consensus interferon and ribavirin in patients with chronic hepatitis C who were nonresponders to prior therapy with either interferon alfa and ribavirin or pegylated interferon and ribavirin
    Chen, K
    Seraphin, P
    Murphy, L
    Shah, N
    HEPATOLOGY, 2005, 42 (04) : 670A - 670A
12345